TAU researchers discover injectable protein to reverse symptoms of dangerous conditions
The creation of new blood vessels in the body, called “angiogenesis,” is usually discussed in connection with healing wounds and tumors. But it’s also an ongoing process in the female reproductive tract, where the growth and breaking of blood vessels is a normal part of the menstrual cycle. But abnormal growth of blood vessels can have painful consequences and resultant pathologies.
Now, Prof. Ruth Shalgi and research associate Dr. Dana Chuderland of Tel Aviv University‘s Sackler Faculty of Medicine have found a potential treatment for this abnormal growth in a potent physiological anti-angiogentic factor, PEDF. Administered by simple injection, this protein reverses the symptoms of related diseases without compromising fertility, according to pre-clinical studies.
These new findings, which have been reported in the Journal of Clinical Endocrinology and Metabolism, Human Reproduction, and Molecular Human Reproduction, could provide relief for millions of women worldwide. This work was done in collaboration with Prof. Rafael Ron-El and Dr. Ido Ben-Ami from Assaf Harofeh Hospital.
Dangers of angiogenesis
There are two primary pathologies associated with angiogenesis in the female reproductive system. One is endometriosis, characterized by the passage of uterine cells to other locations in the body during menstruation, which causes severe pain and reduced fertility. The other is ovarian hyperstimulation syndrome (OHSS), a possible side effect of IVF treatments. This is a potentially life-threatening disease with symptoms including abdominal pain and swelling.
Approximately 170 million women suffer from endometriosis worldwide, and about 10 percent of women receiving IVF treatment develop OHSS. Because no treatment currently exists for either of these conditions, affected women have no choice but to suffer through the symptoms.
In the past few decades, scientists have conducted extensive research on both pro-angiogenic factors such as VEGF and anti-angiogenic factors including PEDF. The effect of PEDF in decreasing abnormal angiogenesis has been extensively investigated in the eye and in tumors. Prof. Shalgi and Dr. Chuderland hypothesized that the same protein could play a role in diseases of the female reproductive system related to blood vessels growth.
In both OHSS and endometriosis, rampant VEGF levels allow for the abnormal vascularization that characterises both diseases. To counteract this effect and restore a healthy angiogenic balance in the reproductive system, the researchers turned to PEDF as a replacement therapy agent. In the lab, Prof. Shalgi and Dr. Chuderland developed mouse models of both endometriosis and OHSS. After preparing the PEDF protein, they injected the mice with it.
The researchers noted a “perfect reversal” of all symptoms, including reduced abdominal swelling in OHSS-induced mice and eradicated lesions in endometriosis. When evaluating whether this protein might affect fertility, they confirmed that PEDF had no negative impact on ovulation or pregnancy rate. In fact, it increased the number of ovulated eggs in the endometriosis model, suggesting improved fertility.
Easing the pain
The next step is to commercialize the protein for therapeutic use, say the researchers, who were the first to prove that this anti-angiogenic protein is active in the reproductive system. This discovery has been patent protected and is currently undergoing commercialization by Ramot, the technology transfer company of TAU (www.ramot.org).
The Latest Bing News on:
Angiogenesis
- Sleep: Your secret weapon to lose weight and boost overall healthon May 8, 2024 at 8:40 pm
Quality sleep is essential for weight loss as it regulates appetite hormones, boosts metabolism, and supports energy levels for physical activity. Here are the top 3 strategies how sleep can be ...
- Summit spikes as Citi launches at Buy on lead asseton May 7, 2024 at 11:56 am
Additionally, the analyst opined that ivonescimab, designed to combine the effects of PD-1 blockade of immunotherapy with the anti-angiogenesis effects of an anti-VEGF, has the potential to receive ...
- Seeing is believing: Observation of migrasomeson May 7, 2024 at 6:32 am
Migrasomes, novel organelles first reported by Professor Li Yu' s team in 2015, are vesicular structures with diameters ranging from 0.5 to 3 micrometers that form on the retraction fibers at the rear ...
- Mixed Results for Combo Treatments for Erectile Dysfunctionon May 6, 2024 at 2:15 pm
The use of investigational combination therapies to treat erectile dysfunction (ED) had mixed outcomes, according to results from two trials presented here. In the ...
- Anti-angiogenesis: The Challenges Aheadon May 3, 2024 at 5:01 pm
In this report, we will discuss some of the AACR data relating to angiogenesis in light of previous results from clinical trials, attempting to outline what has been achieved so far and what are ...
- New experimental evidence unlocks a puzzle in vascular tissue engineeringon April 25, 2024 at 9:25 am
Angiogenesis is a process of forming hierarchical vascular networks in living tissues. Its complexity makes the controlled generation of blood vessels in laboratory conditions a highly challenging ...
- Angiogenesis in brain tumourson April 20, 2024 at 6:51 pm
The growth of both primary and metastatic brain tumours depends on their ability to recruit blood vessels by co-opting the host vessels (co-option), forming new vessels by sprouting (angiogenesis ...
- Clinical translation of angiogenesis inhibitorson April 17, 2024 at 5:00 pm
Angiogenesis inhibitors are a relatively new class of cancer drugs. The biological and biochemical characteristics of angiogenesis inhibitors, however, differ from conventional cytotoxic chemotherapy.
- New alveolar soft-part sarcoma chip can mimic the microenvironment during angiogenesison March 22, 2024 at 7:23 am
Cancer, the second leading cause of death worldwide, is more likely to respond to effective treatment if identified early before metastasizing, resulting in a greater probability of surviving.
- Stem cells, angiogenesis and muscle healing: a potential role in massage therapies?on January 23, 2023 at 8:18 pm
Several studies have also shown that vascular endothelial growth factor (VEGF) can increase the efficiency of skeletal muscle repair by increasing angiogenesis and, at the same time, reducing the ...
The Latest Google Headlines on:
Angiogenesis
[google_news title=”” keyword=”angiogenesis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”] [/vc_column_text]The Latest Bing News on:
Endometriosis
- Battling Endometriosis, Danielle Collins Vows to Bring About a Change in Women's Health Issues With an Upcoming Initiativeon May 8, 2024 at 2:30 pm
With just months left before she ends her tennis career, Danielle Collins is already thinking about the next phase of her life. The post Battling Endometriosis, Danielle Collins Vows to Bring About a Change in Women's Health Issues With an Upcoming Initiative appeared first on EssentiallySports.
- Endometriosis Patients Turn to Lifelong Care as Disease Understanding Evolveson May 8, 2024 at 6:54 am
Pelvic Rehabilitation Medicine (PRM), a national leader in endometriosis care, believes when it comes to endometriosis, lifelong care is the only way to go. There is more to treatment and care than excision surgery alone,
The Latest Google Headlines on:
Endometriosis
[google_news title=”” keyword=”endometriosis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]